CapsoVision (FRA:H6U) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:H6U CapsoVision Inc FRA:H6U
20 GF Score
Price €5.30
! 1 Warning Sign
View Full Analysis

What is CapsoVision FFO?

FFO (Funds from operations) only applies to REITs.

FRA:H6U
20GF Score
CapsoVision Inc FRA:H6U
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CapsoVision Business Description

Other Exchanges CV:USA
Address 18805 Cox Avenue, Suite 250, Saratoga, CA, USA, 95070
CapsoVision Inc is a commercial-stage medical technology enterprise that innovates, manufactures, and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal (GI) system. The company's core technology platform is an orally ingestible capsule including multiple cameras facilitating 360-degree imaging, light-emitting diodes for measurement, onboard memory storage, and battery life permitting recording and onboard storage of video images. CapsoVision's products consist of the on-market CapsoCam Plus, directed at the small intestines, and the in-development CapsoColon 3D, directed at the large intestines. Geographically, the company generates the majority of its revenue from the United States.
20GF Score

Get the complete analysis for FRA:H6U

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€5.30
Price